Hobbs Wealth Management’s AbbVie ABBV Stock Holding History

Hobbs Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,247	Closed	-$289K	–	23
2025 Q3	$289K	Buy	+1,247	New	+$254K	0.24%	43
2025 Q2	–	Sell	-976	Closed	-$204K	–	50
2025 Q1	$204K	Buy	+976	New	+$190K	0.23%	49

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Hobbs Wealth Management's ABBV Position: Q4 2025 in Review

Hobbs Wealth Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 1,247 shares — an estimated $289K sold.

Hobbs Wealth Management first reported a position in ABBV in Q1 2025 and held it in 2 quarters. The position peaked at $289K in Q3 2025. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Hobbs Wealth Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Hobbs Wealth Management sold 1,247 AbbVie shares in Q4 2025, an estimated $289K.
Hobbs Wealth Management first reported a position in AbbVie in Q1 2025 and held it in 2 quarters.
Hobbs Wealth Management's AbbVie position peaked at $289K in Q3 2025.
4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Hobbs Wealth Management's 13F filing for Q4 2025, filed 29 Jan 2026.